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Correction to: Nature Communications https://doi.org/10.1038/s41467-018-04711-w, published online 11 Jun 2018.
In the original version of this Article, references in the Methods section incorrectly referred to references in the Supplementary
References section. The relevant references (now numbered 20, 27, 42, 47, 69–80) have been removed from the Supplementary
References section of the Supplementary Information ﬁle and added to the References section of the main manuscript, in both the PDF
and HTML versions of the Article.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and
reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit
line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use,
you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
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